Pharmaron Beijing, a fully integrated contract research and manufacturing organization, completed the acquisition of Absorption Systems, a biotechnology company, for $138m. "We are very pleased to have Absorption Systems join the Pharmaron Group, and this acquisition, once again, demonstrates our commitment to becoming a global leader in drug R&D services. The addition of Absorption Systems further expands and strengthens our services and global network with strategic presence in life science hubs in the US. We have been impressed with the achievement by Absorption Systems and its high caliber team and look forward to an exciting future together," Boliang Lou, Pharmaron Chairman and CEO.